PHARMACEUTICAL INDUSTRIES LIMITED, LLC. – Trademark Portfolio
Entity Type: 16
PHARMACEUTICAL INDUSTRIES LIMITED, LLC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SAFEDOSE. The owner is based in Chicago, IL.
737 North Michigan Avenue Suite 2350
Chicago, IL 60611
Showing of trademarks Trademarks
Trademark Classifications
PHARMACEUTICAL INDUSTRIES LIMITED, LLC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does PHARMACEUTICAL INDUSTRIES LIMITED, LLC. have?
PHARMACEUTICAL INDUSTRIES LIMITED, LLC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does PHARMACEUTICAL INDUSTRIES LIMITED, LLC. file in?
PHARMACEUTICAL INDUSTRIES LIMITED, LLC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PHARMACEUTICAL INDUSTRIES LIMITED, LLC.'s most well-known trademarks?
PHARMACEUTICAL INDUSTRIES LIMITED, LLC.'s registered trademark portfolio includes well-known marks such as SAFEDOSE. These are among 1 currently registered trademark in the portfolio.
What is PHARMACEUTICAL INDUSTRIES LIMITED, LLC.'s trademark registration success rate?
PHARMACEUTICAL INDUSTRIES LIMITED, LLC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.